Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Luvalis Pharma ApS
APS
Active
Advertising protection
CVR 45786684
Njalsgade 21F, 2300
København S
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2025 · <1 year old
1 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Luvalis Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MG
Mikkel Geertsen
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BY
Bo Yde Svendsen
Chairman
Chairman
2025
JH
Jonas Hammershaimb Mosbech
Deputy Chairman
Deputy Chairman
2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Ragdoll Invest ApS
Company
33.33–49.99%
33.33–49.99%
2025
BOSV ApS
Company
33.33–49.99%
33.33–49.99%
2025
Mixin ApS
Company
33.33–49.99%
33.33–49.99%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Luvalis Pharma ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
